Coronavirus and Parkinson’s: experts answer the big questions
Author: Caithlin NgPublished: 26 March 2020
Prep: Cook: Serves:
From dealing with social isolation to deciding whether nursing homes are safe during the global coronavirus pandemic – we share the key takeaways from a Facebook Live event organised by US charity the Parkinson’s Foundation’s – ‘Ask the Experts: Coronavirus and Parkinson’s’
People with Parkinson’s are considered to be at a higher risk of severe illness from coronavirus (Covid-19). In a recent Facebook Live event by the Parkinson’s Foundation, ‘Ask the Experts: Coronavirus and Parkinson’s’, two scientists shared essential advice with the Parkinson’s community about the precautions they should take.
We highlight five key takeaways from Dr Michael Okun, national medical director of the Parkinson’s Foundation and chair of neurology at the University of Florida, US, and Dr Frederick Southwick, professor of medicine and former chief of infectious diseases at the University of Florida, US.
1. Should people with Parkinson’s socially isolate themselves?
Yes, they should. Strict social distancing may seem
“draconian”, Dr Southwick said, but “is the only way to save lives”. Pointing
to the effectiveness of China’s quarantine, he explained that the country’s
rate of infections flattened after the measure was introduced. High-risk groups
like Parkinson’s patients must be especially mindful of social distancing.
“You don’t want to panic, but a little fear of infectious
diseases is a good thing,” he explained. “People who go out are endangering
family members with Parkinson’s. The solution for people with Parkinson’s,
unfortunately, is to stay away from everybody.”
“The Parkinson’s Foundation is recommending that we stay at home and limit visitors,” added Dr Okun.
2. Are nursing homes and rehab facilities safe to visit at this time?
Avoid visiting nursing homes and rehab facilities as far as possible. “If you can get out of these facilities, you are probably safer at home where you can control the environment,” Dr Southwick said. If it cannot be helped, he advised patients to “watch the infection, call and ask the people in charge there whether they are following Centers for Disease Control and Prevention guidelines.”
Amongst other things, watch out for the frequency with which workers wash their hands and the limits on visitors.
However, Doctor Okun advised against rushing to remove people from residential care: “Talk it over with your doctor and think about the risks and benefits. Do you have the right equipment, gear and medicine? You may actually make them less safe rather than more safe.”
3. How can I look after my mental health when self-isolating?
Dr Okun highlighted the importance of communicating with others while isolating at home: “Just reach out – I can’t tell you how awesome the power of social interaction is in calming people down in a crisis.”
Dr Southwick offered some practical ways of coping with ‘cabin fever’: “You can go out and walk in the woods, or to a park if you’re far away from others.” He said pets could be very helpful for anyone social distancing.
“There is no evidence that pets can carry the virus, so it can be very soothing to have a cat or a dog.”
4. Should I visit my doctor at the moment?
Unless it’s an urgent situation, you should reschedule any
appointments. Dr Okun suggests preparing a three-month supply of medication,
and collecting it using a ‘drive-through’ pharmacy service. Dr Southwick added
that tele-medicine can be a great way of communicating with doctors.
“You really do not need to have the physicians next to you making the decision. We have electronic records, FaceTime and Zoom. There are a lot of smart tools now that allow you to get virtual care.”
Dr Okun said that any patients with severe problems should phone before visiting a doctor’s office to give staff time to prepare, and that anyone heading to an emergency room with a cough, fever or respiratory infection symptoms should call beforehand to allow them to arrange isolation.
5. Should I wear a mask to stop myself being infected?
Although many people have rushed to buy face masks, Dr
Southwick suggested that this may actually be unhelpful in the long run: “A
mask mostly protects you from spreading something to somebody else, but if you
aren’t infected, you adjust the mask and touch your face so you may actually
have a higher likelihood of infection.”
Dr Southwick added that the large numbers of people buying up stock posed a significant problem for healthcare organisations.
“In healthcare, where we’re in high likelihood of coming
in contact, yes, we need the masks.” He added that if the public “hoards all
the masks” healthcare providers won’t be able to access them.
Watch the full webinar here:
For up-to-date information about Covid-19 please get in touch with your healthcare authorities and check updates provided by reliable Parkinson’s organisations.
How have you been affected by the coronavirus?
We will be doing all we can to share useful information about Covid-19 with you as the situation develops – and we need your help. To share your experience or tell us the topics you want Parkinson’s Life to cover during the pandemic, please leave a comment or email email@example.com.
For more information about Covid-19 please visit the EPDA website.
Campaigners are being asked to contact the EU directly
3 days ago
New biotech to drive forward GDNF treatment for Parkinson’s disease
UK charity Parkinson’s UK is creating a new company, Vivifi Biotech, to develop a treatment with potential to stop or reverse Parkinson’s disease. The experimental therapy surgically distributes GDNF, a protein that is naturally produced by the brain to protect cells, directly into the brain. The charity previously funded a clinical trial to investigate whether boosting GDNF levels could regenerate dying brain cells in people with Parkinson’s. Over the next two years, it will invest up to £800,000 to prepare for a second trial. Arthur Roach, head of research at Parkinson’s UK, said: “While our initial trial didn’t meet its critical endpoint, it did reveal robust evidence indicating that GDNF can possibly reverse Parkinson’s. This is why Parkinson’s UK is committed to continuing research into this potential treatment.” Vivifi Biotech, Roach added, will “bring the right people together to plan a new trial that meets the needs of patients, regulatory…
New wearable medical device for Parkinson’s disease to launch this year
The Imperial College London Innovation Fund, UK, has invested £205,000 to support UK-based tech company Charco Neurotech in its development of a non-invasive medical device for people with Parkinson’s disease. CUE1, a circular device that attaches to the sternum with medical adhesives, uses specialised vibration to help alleviate physical symptoms of Parkinson’s disease. Initial user testing among people with the condition found that the device improved movement by an average of 16%, with testers reporting benefits for walking and fine motor tasks. Lucy Jung, CEO and co-founder of Charco Neurotech, said: “We believe that CUE1 has the potential to significantly improve [Parkinson’s disease] symptoms through its unique controlled vibration technology. We are excited to continue our work on the device and we look forward to the outcome of our proposed clinical trials.” Charco Neurotech will use the Imperial College investment to initiate a clinical trial and fund the device’s manufacture for…
New study brings scientists a “vital step” closer to understanding Parkinson’s disease
A new study from scientists at the University of Cambridge, UK, has brought researchers “a vital step” closer to discovering the origins of Parkinson’s disease. The research, published in the scientific journal ‘Nature Communications’, offered insights on the protein alpha-synuclein, which clumps together in the neurons of people with Parkinson’s. The study focused on how the protein functions in those without the condition and revealed that it sticks to the inner side of the plasma membrane of nerve cells, but not the outer membrane – an insight that could help in the search for a cure. Lead study author, Dr Giuliana Fusco, said: “This study could unlock more information about this debilitating neurodegenerative disorder that can leave people unable to walk and talk. If we want to cure Parkinson’s, first we need to understand the function of alpha-synuclein, a protein present in everyone’s brains.”